Find information on thousands of medical conditions and prescription drugs.

Mediterranean fever

Familial Mediterranean fever (FMF) is a hereditary inflammatory disorder that affects groups of patients originating from around the Mediterranean Sea (hence its name). It is prominently present in the Armenian people (up to 1 in 7 affected), Sephardi Jews (and, to a much lesser extent, Ashkenazi Jews), people from Turkey, the Arab countries and Lebanon. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
Mac Ardle disease
Macroglobulinemia
Macular degeneration
Mad cow disease
Maghazaji syndrome
Mal de debarquement
Malaria
Malignant hyperthermia
Mallory-Weiss syndrome
Malouf syndrome
Mannosidosis
Marburg fever
Marfan syndrome
MASA syndrome
Mast cell disease
Mastigophobia
Mastocytosis
Mastoiditis
MAT deficiency
Maturity onset diabetes...
McArdle disease
McCune-Albright syndrome
Measles
Mediterranean fever
Megaloblastic anemia
MELAS
Meleda Disease
Melioidosis
Melkersson-Rosenthal...
Melophobia
Meniere's disease
Meningioma
Meningitis
Mental retardation
Mercury (element)
Mesothelioma
Metabolic acidosis
Metabolic disorder
Metachondromatosis
Methylmalonic acidemia
Microcephaly
Microphobia
Microphthalmia
Microscopic polyangiitis
Microsporidiosis
Microtia, meatal atresia...
Migraine
Miller-Dieker syndrome
Mitochondrial Diseases
Mitochondrial...
Mitral valve prolapse
Mobius syndrome
MODY syndrome
Moebius syndrome
Molluscum contagiosum
MOMO syndrome
Mondini Dysplasia
Mondor's disease
Monoclonal gammopathy of...
Morquio syndrome
Motor neuron disease
Motorphobia
Moyamoya disease
MPO deficiency
MR
Mucopolysaccharidosis
Mucopolysaccharidosis...
Mullerian agenesis
Multiple chemical...
Multiple endocrine...
Multiple hereditary...
Multiple myeloma
Multiple organ failure
Multiple sclerosis
Multiple system atrophy
Mumps
Muscular dystrophy
Myalgic encephalomyelitis
Myasthenia gravis
Mycetoma
Mycophobia
Mycosis fungoides
Myelitis
Myelodysplasia
Myelodysplastic syndromes
Myelofibrosis
Myeloperoxidase deficiency
Myoadenylate deaminase...
Myocarditis
Myoclonus
Myoglobinuria
Myopathy
Myopia
Myositis
Myositis ossificans
Myxedema
Myxozoa
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Clinical symptoms

Attacks

There are seven types of attacks. 90% of all patients have their first attack before they are 20 years old. All develop over 2-4 hours and last anytime between 6 hours and 4 days. Most attacks involve fever:

  1. Abdominal attacks, featuring abdominal pain affecting the whole abdomen with all signs of acute abdomen (e.g. appendicitis). They occur in 95% of all patients and may lead to unnecessary laparotomy. Incomplete attacks, with local tenderness and normal blood tests, have been reported.
  2. Joint attacks, occurring in large joints, mainly of the legs. Usually, only one joint is affected. 75% of all FMF patients experience joint attacks.
  3. Chest attacks with pleuritis (inflammation of the pleural lining) and pericarditis (inflammation of the pericardium). Pleuritis occurs in 40%, but pericarditis is rare.
  4. Scrotal attacks due to inflammation of the tunica vaginalis. This occurs in up to 5% and may be mistaken for acute scrotum (i.e. testicular torsion)
  5. Myalgia (rare in isolation)
  6. Erysipeloid (a skin reaction on the legs, rare in isolation)
  7. Fever without any symptoms (25%)

Complications

AA-amyloidosis with renal failure is a complication and may develop without overt crises. AA (amyloid protein) is produced in very large quantities during attacks and at a low rate between them, and accumulates mainly in the kidney, as well as the heart, spleen, gastrointestinal tract and the thyroid.

There appears to be an increase in the risk for developing particular vasculitis-related diseases (e.g. Henoch-Schoenlein purpura), spondylarthropathy, prolonged arthritis of certain joints and protracted myalgia.

Diagnosis

The diagnosis is clinically made on the basis of the history of typical attacks, especially in patients from the ethnic groups in which FMF is more highly prevalent. An acute phase response is present during attacks, with high C-reactive protein levels, an elevated white blood cell count and other markers of inflammation. In patients with a long history of attacks, monitoring the renal function is of importance in predicting chronic renal failure.

A genetic test is also available now that the disease has been linked to mutations in the MEFV gene. Sequencing of exons 2, 3, 5, and 10 of this gene detects an estimated 97% of all known mutations.

Disease mechanism

Pathophysiology

Virtually all cases are due to a mutation in the MEFV gene, which codes for a protein called pyrin or marenostenin. This was discovered in 1997 by two different groups. Various mutations of this gene lead to FMF, although some mutations cause a more severe picture than others. Mutations occur in exons 2, 3, 5 and 10.

Read more at Wikipedia.org


[List your site here Free!]


First detection of spotted fever group Rickettsiae in Ixodes ricinus from Italy - Dispatches
From Emerging Infectious Diseases, 9/1/02 by Tiziana Beninati

Ixodes ricinus from Italy were examined for the first time to detect whether rickettsiae were present. Using molecular methods, we detected three different spotted fever group rickettsiae, including Rickettsia helvetica. Our results raise the possibility that bacteria other than R. conorii are involved in rickettsial diseases in Italy.

**********

The genus Rickettsia comprises obligately intracellular, gram-negative bacteria. Before sequence-based classification methods were introduced, the genus was divided into two groups: the typhus group (TG), which included R. prowazekii, R. typhi, and R. canada, and the spotted fever group (SFG), which comprised all others. Recent phylogenetic studies of genes such as gltA, ompA, "gene D," and that encoding the 17-kDa protein (hereafter referred to as "17kDa") have shown that these two groupings are not consistent with species relationships; consequently, they have been modified (summarized in [1]). The TG now comprises only R. prowazekii and R. typhi, while the SFG contains seven divergent lineages: the R. rickettsii group, R. japonica, R. montana, the R. massiliae group, R. helvetica, R. felis, and the R. akari group. The AB bacterium, R. bellii, and R. canada cluster outside both the TG and SFG in most analyses (1).

Members of the SFG rickettsiae are usually associated with ixodid ticks, which transfer them to vertebrates via salivary secretions and between themselves transtadially and transovarially. Several tick-borne rickettsiae are causative agents of human or animal diseases. The prevalences of these diseases are primarily dependent on the geographic distribution of host ticks, which act as both vector and reservoir. Among rickettsiae found in Europe, R. conorii is probably the most well known. This bacterium, transmitted by Rhipicephalus sanguineus, causes "boutonneuse" or Mediterranean spotted fever (MSF), an endemic disease in several countries. Until recently, MSF was thought to be the only rickettsial disease prevalent in Europe, but in recent years some new human rickettsioses have been attributed to bacteria previously considered of unknown pathogenicity (2). An example is Rickettsia helvetica, which was originally isolated in 1979 from Ixodes ricinus but was shown to have pathologic relevance only in 1999, when it was associated with fatal perimyocarditis in two Swedish men (3). In addition, R. helvetica stimulated a specific antibody response in a man in France who had low-grade fever, headache, and myalgia (4).

In Italy, the only rickettsia isolated from humans and ticks thus far has been R. conorii. Since its host, Rh. sanguineus, favors warm climates, MSF is more common in central and southern Italy (5,6). In the years 1992-1998, approximately 8,500 cases of human rickettsioses presumed to be MSF were reported to the Italian Ministry of Health. Regarding the distribution of cases in different parts of Italy, some central (Lazio) and southern (Sardinia, Sicily, and Calabria) regions of the country have a particularly high morbidity rate, reaching an average of 11.9 cases for every 100,000 inhabitants in Sardinia, compared with the national average of 2.1.

The diagnosis of MSF in Italy usually depends on clinical evidence supported by serologic confirmation, mainly by the microimmunofluorescence (MIF) technique. A major limitation of MIF is cross-reactivity, which renders it unable to differentiate between various SFG rickettsiae (4). Thus, some cases of MSF, in Italy, especially where the disease is not endemic, may in fact be due to other rickettsiae.

I. ricinus is found with high prevalence in the Italian Alps and Apennines (reaching 96% of all ticks collected in some areas) and in almost all other Italian regions that contain humid, forested habitats (7). While all life stages of Rh. sanguineus are mainly associated with dogs, I. ricinus can feed on >200 host species, primarily wild rodents and ruminants. In a survey in Liguria of ticks recovered from people, most ticks (89.3%) were I. ricinus; Rh. sanguineus was recorded less frequently (9.8%) (8).

To date, no studies have been conducted on potential rickettsiae in Italian ticks, other than Rhipicephalus spp. Recently, various Rickettsia species have been found in I. ricinus from other European countries, including R. helvetica in Switzerland, France, Sweden, Slovenia, and Portugal (4) and Rickettsia spp. IRS3/4 in Slovakia (9). To check whether such bacteria are also present in Italian I. ricinus, we studied specimens from three regions. We used molecular-sequence-based identification techniques, which offer high sensitivity and specificity compared with serologic tests and circumvent the need for bacterial culturing.

The Study

A total of 109 I. ricinus specimens were collected in northern and central Italy (Figure 1), identified by using standard taxonomic keys, and stored at-20[degrees]C. Specifically, 89 ticks (70 adults and 19 nymphs) were collected by dragging vegetation in different parts of Trentino Province in April-October 1997 and 1999, and 10 ticks (7 adults and 3 nymphs) by dragging in Feltre (Veneto Region) in March 2000. Ten more ticks (7 adults and 3 nymphs) were collected from a patient at the Ospedale di Careggi in Firenze in May 1997. The man had been bitten in Parco Nazionale delle Foreste Casentinesi (Toscana Region; see Figure 1) a number of hours earlier but did not display any illness. M1F tests with R. conorii antigens were performed on his arrival at the hospital and again 4 weeks later: results were negative in each instance. Tick samples were placed in 50 [micro]L of 10 mM Tris*HCl (pH 8.0), heated at 90[degrees]C for 10 min, crushed with a sterile plastic homogenizer, and treated with 10 [micro]g of proteinase K at 50[degrees]C for 3 h. Polymerase chain reaction (PCR) of a 341-bp portion of gltA was performed by using the primers Rp CS.877p and Rp CS.1258n under conditions previously described (10). These primers were chosen for an initial screening because they are known to amplify all rickettsiae (11).

[FIGURE 1 OMITTED]

One hundred nine PCRs were performed, and nine positives (two adult females, three adult males, and four nymphs) were found. An initial estimate of the overall prevalence in Italian I. ricinus is thus 8.25%. To better establish intrageneric relationships, the nine positive samples were subjected to further PCR analysis with the primer pairs Rr 17.61p/Rr 17.492n and Rr 190.70p/Rr 190.602n (10), which amplified 394-bp and 488-bp portions of 17kDa and ompA, respectively. PCR bands for all three genes were then sequenced directly by using an ABI PRISM sequencer (Perkin-Elmer, Foster City, CA). To compare the sequences obtained during this study with those of other rickettsiae, sequences present in GenBank were selected by means of BLAST as well as on the basis of previous reports (1,12). Sequences were converted to their putative amino acid sequences and aligned by using the program Clustal X (ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX/). Based on these alignments, nucleotide alignments were performed manually, and phylogenetic relationships were inferred by maximum likelihood (ML). The appropriate model of sequence evolution was determined by Modeltest 3.06 (http://zoology.byu.edu/crandall_lab/modeltest.htm), and trees were produced using the program TreePuzzle 5.0 (www.tree-puzzle.de), which provides branch lengths as well as quartet puzzling support values at each node with >50% support.

Comparisons of the sequences identified with those from closely related SFG Rickettsia spp. are shown in the Table; Figure 2 shows the results of phylogenetic analysis, gltA-based results (Figure 2a) show that all strains detected are SFG rickettsiae. For 17kDa (Figure 2b), no identical sequences for IrITA2 and IrITA3 were present in GenBank, and they clustered with R. cooleyi (isolated from I. scapularis in Texas [13]). ompA was the most variable of the three genes analyzed (Figure 2c) and could only be amplified from IrITA2 and IrITA3. Consistent with the results from gltA, ompA from IrITA2 was 100% identical to IrR/Munich; however, two substitutions were found between these two sequences and that of 1RS4. Notably, for ompA, the cluster to which IrITA2 and IrITA3 belong also contains a strain detected in Spain (14). This finding suggests that these bacteria may be widespread in Europe. On the basis of ompA (and 17kDa) sequences, the clade containing IrITA2 and IrITA3 was closest to a clade containing R. cooleyi and an endosymbiont (10), both hosted by I. scapularis. All previous attempts to amplify ompA from R. helvetica by using various primers have failed, which suggests that the gene is either absent or too variable to work with primers designed from other SFG bacteria (12). This would explain why we were unable to amplify ompA from IrITA1. Taken together, the results from the three genes indicate that the clade containing IrITA2 and IrITA3 represents a lineage divergent from the seven described previously (1).

[FIGURE 2A-2C OMITTED]

Conclusions

Our results represent the first demonstration of rickettsiae in Italian I. ricinus and the first use of molecular-sequence-based methods to identify rickettsiae in Italy. One bacterium, R. helvetica, occurs in several parts of Europe and has been implicated as a human pathogen. The other two strains have only recently been discovered in I. ricinus from Slovakia and Germany. Whether they are pathogenic is not known, but since other rickettsiae of previously unknown pathogenicity have subsequently been shown to be associated with disease (R. helvetica and R. slovaca [15]), these new strains warrant attention.

Several studies on rickettsioses in Italy have been published in the last two decades, and they all report R. conorii as the causative agent. As MSF is the only known rickettsiosis in Italy, diagnostic tests use R. conorii as the only antigen for serologic assays (16,17). However, since SFG rickettsiae cause cross-reactions, confusion about the source of the illness may occur. Although antibiotic therapy is generally effective for all SFG-related diseases, a better understanding of how different rickettsiae cause different symptoms will only come with their correct identification. During 1996-1999 in the regions we sampled, 23 rickettsioses (assumed to be MSF) were reported from Veneto, 42 from Toscana, and 3 from Trentino Province (Italian Ministry of Health, unpub, data). While many were likely to be MSF cases, the possibility exists that some were caused by other SFG (perhaps R. helvetica).

Unlike most studies, one serosurvey in northeastern Italy (18) used the complement-fixation test, which is less prone to cross-reactions (19); none of the sera tested was found positive for antibodies to rickettsiae. This finding may be explained by the use of R. conorii, R. rickettsii, R. typhi, and R. akari as the only antigens. Serosurveys such as these could therefore benefit from the use of antigens from the bacteria identified in our study. I. ricinus is one of the most abundant tick species in Italy, having a very low host specificity and a record of attacking large numbers of humans (8). The results reported here add SFG rickettsiae to the list of potentially dangerous pathogens that Italian I. ricinus carry.

Acknowledgments

We thank C. Bandi for advice; V. Tagliapietra, L. Agostini, S. De Felici, R. Luise, and A. Iori for help with tick collection; and A. Bartoloni for ticks and clinical information about the patient in Firenze.

This work was supported by the Centro di Ecologia Alpina, Trento. N. L is supported by the Science and Technology Agency of Japan.

References

(1.) Sekeyova Z, Roux V, Raoult D. Phylogeny of Rickettsia spp. inferred by comparing sequences of `gene D', which encodes an intracytoplasmic protein. Int J Syst Evol Microbiol 2001;51:1353-60.

(2.) Parola P, Raoult D. Tick-borne bacterial diseases emerging in Europe. Clin Microbiol Intact 2001;7:80-3.

(3.) Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet 1999;354:1169-73.

(4.) Fournier PE, Grunnenberger F, Jaulhac B, Gastinger G, Raoult D. Evidence of Rickettsia helvetica infection in humans, eastern France. Emerg Infect Dis 2000;6:389-92.

(5.) Tringali Ct Intonazzo V, Perna AM, Mansueto S, Vitale G, Walker DH. Epidemiology of Boutonneuse fever in western Sicily. Distribution and prevalence of spotted fever group rickettsial infection in dog ticks (Rhipicephalus sanguineus). Am J Epidemiol 1986;123:721-7.

(6.) Scaffidi V. Current endemic expansion of boutonneuse fever in Italy. Minerva Med 1981;72:2063-70.

(7.) Genchi C, Manfredi MT. Tick species infesting ruminants in Italy: ecological and bio-climatic factors affecting the different regional distribution. Parassitologia 1999;41(Suppl 1):41-5.

(8.) Manfredi MT, Dini V, Piacenza S, Genchi C. Tick species parasitizing people in an area endemic for tick-borne diseases in north-western Italy. Parassitologia 1999;41:55540.

(9.) Sekeyova Z, Fournier PE, Rehacek J, Raoult D. Characterization of a new spotted fever group rickettsia detected in Ixodes ricinus (Acari: Ixodidae) collected in Slovakia. J Med Entomol 2000;37:707-13.

(10.) Noda H, Munderloh UG, Kurtti TJ. Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals. Appl Environ Microbiol 1997;63:3926-32.

(11.) Roux V, Rydkina E, Eremeeva M, Raoult D. Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae. Int J Syst Bacteriol 1997;47:252-61.

(12.) Fournier PE, Roux V, Raoult D. Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rOmpA. Int J Syst Bacteriol 1998;48 Pt 3:839-49.

(13.) Billings AN, Teltow GJ, Weaver SC, Walker DH. Molecular characterization of a novel Rickettsia species from Ixodes scapularis in Texas. Emerg Infect Dis 1998;4:305-9.

(14.) Marquez FJ, Muniain MA, Soriguer RC, Izquierdo G, Rodriguez-Bano J, Borobio MV. Genotypic identification of an undescribed spotted fever group rickettsia in Ixodes ricinus from southwestern Spain. Am J Trop Med Hyg 1998;58:570-7.

(15.) Raoult D, Berbis P, Roux V, Xu W, Maurin M. A new tick-transmitted disease due to Rickettsia slovaca. Lancet 1997;350:112-3.

(16.) Tinelli M, Maccabruni A, Michelone G, Zambelli A. Mediterranean spotted fever in Lombardy: an epidemiological, clinical and laboratory study of 76 cases in the years 1977-1986. Eur J Epidemiol 1989;5:516-20.

(17.) Mansueto S, Vitale G, Miceli MD, Tringali G, Quartararo P, Picone MD, et al. A sero-epidemiological survey of asymptomatic cases of Boutonneuse fever in western Sicily. Trans R Soc Trop Med Hyg 1984;78:16-8.

(18.) Nuti M, Amaddeo D, Crovatto M, Ghionni A, Polato D, Lillini E, et al. Infections in an Alpine environment: antibodies to hantaviruses, leptospira, rickettsiae, and Borrelia burgdorferi in defined Italian populations. Am J Trop Med Hyg 1993;48:20-5.

(19.) La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997;35:2715-27.

Address for correspondence: Nathan Lo, Dipartimento di Patologia Animale, Igiene e Sanita Pubblica Veterinaria, Universita di Milano, Via Celoria 10, 20133 Milano, Italy; fax: 39 02 5031 8095; e-mail: nathanlo@affrc.go.jp

Ms. Beninati is a doctoral candidate of the veterinary faculty of the University of Milan, Italy. Her research interests include tickborne diseases and population genetics of I. ricinus.

Tiziana Beninati, * Nathan Lo, * ([dagger]) Hiroaki Noda, ([dagger]) Fulvio Esposito, ([double dagger]) Annapaola Rizzoli, ([section]) Guido Favia, ([double dagger]) and Claudio Genchi, * ([section])

* Universita degli Studi di Milano, Italy; ([dagger]) National Institute of Agrobiological Sciences, Tsukuba, Japan; ([double dagger]) Universita di Camerino, Macerata, Italy; and ([section]) Centro di Ecologia Alpina, Trento, Italy

COPYRIGHT 2002 U.S. National Center for Infectious Diseases
COPYRIGHT 2002 Gale Group

Return to Mediterranean fever
Home Contact Resources Exchange Links ebay